Trial set for doctor and ketamine queen in Matthew Perry case
- A trial date has been set for two individuals charged in connection with Matthew Perry's death, scheduled for March 4, 2025.
- Plasencia and Sangha face multiple charges, including conspiracy to distribute ketamine and have pleaded not guilty.
- The case underscores the serious implications of ketamine misuse and the legal consequences for those involved.
A trial is set to begin on March 4, 2025, for two individuals charged in connection with the death of actor Matthew Perry, who passed away in October 2023. The pretrial hearing is scheduled for February 19, 2025. The accused, Plasencia and Sangha, were arrested on August 15 and face multiple charges, including conspiracy to distribute ketamine and falsifying medical records. They have pleaded not guilty to the charges. Matthew Perry's death was attributed to the acute effects of ketamine and subsequent drowning, as reported by the Los Angeles County Medical Examiner's Office. He was found in a hot tub at his home, and prosecutors allege that Plasencia and Sangha contributed to his death by distributing ketamine during the weeks leading up to the incident. Plasencia is accused of selling ketamine vials to Perry and teaching his personal assistant how to inject the drug. Sangha is also facing serious charges, including maintaining a drug-involved premises and possession with intent to distribute methamphetamine. Prosecutors claim she continued to sell ketamine despite knowing its dangers, particularly after a previous overdose death linked to her sales. Federal agents discovered over 70 vials of ketamine and other illegal drugs at her residence during a search. If convicted, Plasencia could face significant prison time, with up to 10 years for each ketamine-related count and 20 years for falsification. Sangha faces a maximum sentence of life in prison. The case highlights the ongoing issues surrounding the misuse of ketamine, both as a therapeutic drug and as a substance abused in social settings.